TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 46 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | -33.3% | 4,326 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -50.0% | 4,326 | +32.7% | 0.00% | – |
| Q2 2016 | $6,000 | -25.0% | 3,261 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -68.0% | 3,261 | 0.0% | 0.00% | – |
| Q4 2015 | $25,000 | +47.1% | 3,261 | 0.0% | 0.00% | – |
| Q3 2015 | $17,000 | -29.2% | 3,261 | +22.7% | 0.00% | – |
| Q2 2015 | $24,000 | +41.2% | 2,658 | 0.0% | 0.00% | – |
| Q1 2015 | $17,000 | +70.0% | 2,658 | +50.9% | 0.00% | – |
| Q4 2014 | $10,000 | -16.7% | 1,761 | 0.0% | 0.00% | – |
| Q3 2014 | $12,000 | – | 1,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 370,000 | $1,602,000 | 0.67% |